Surgery Timing and TREM2 Shape CAR-T Activity in Glioblastoma Models
A peer-reviewed study finds that glioblastoma surgery drives TREM2-positive myeloid remodeling that impairs CAR-T function, and that preoperative CAR-T dosing outperformed postoperative dosing in mouse models.
